#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hidradenitis Primary amyloidosis Penile squamous cell carcinoma Systemic candida Crigler-Najjar syndrome Gaucher's disease type I Fragile X syndrome Antisynthetase syndrome B-cell small lymphocytic lymphoma Cushing's syndrome Neuronal ceroid lipofuscinosis Factor VIII deficiency Non-Hodgkin's lymphoma unspecified histology indolent Arrhythmogenic right ventricular dysplasia Nasopharyngeal cancer More trials…

    Learn about Rare Diseases

    Nodal marginal zone B-cell lymphoma – Life with Disease Lysosomal storage disorder – Diagnostics Extranodal marginal zone B-cell lymphoma (MALT type) – Trials in Disease Langerhans cell sarcoma – Basic Information Waldenstrom’s macroglobulinaemia recurrent – Treatment SAPHO syndrome – Basic Information Acquired haemophilia Breast angiosarcoma Brain stem glioma – Trials in Disease Nodal marginal zone B-cell lymphoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Piritramide Vafidemstat Faricimab Dalbavancin Dexrazoxane Hydrochloride ALLO-QUADCAR01-T Remestemcel Egl-001 ALXN2420 Serine Alnuctamab Laronidase Regn9933 JNJ-75276617 Valine Mk-6194 Ligelizumab Nelivaptan MZE829 Belzupacap Sarotalocan More therapies…

    Learn about Your Condition

    Renal cancer metastatic Barrett's oesophagus Hand dermatitis Renal disorder Nephropathy Adenocarcinoma gastric Colorectal cancer metastatic Congenital aplastic anaemia Red blood cell abnormality Vesicoureteric reflux Food allergy Choroidal neovascularisation Vasoplegia syndrome Anxiety disorder Univentricular heart More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on Fluconazole and Sodium Chloride to Prevent Fungal Infections in Patients Undergoing Cystectomy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Fungal infection
    Investigated Drugs:
    • Fluconazole
    • Sodium Chloride
    Denmark

  • Study on Abdominal Aortic Aneurysm Treatment with Allogeneic Adipose-Derived Mesenchymal Stem Cells for Patients Undergoing Endovascular Repair

    Recruiting

    2 1 1
    Investigated Diseases:
    • Aortic aneurysm
    Investigated Drugs:
    • Allogeneic Adipose-Derived Mesenchymal Stem Cells Expanded
    Spain

  • Study of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Isatuximab
    • Dexamethasone
    Austria Germany

  • Study on the Effect of Genetic Testing and Training on Muscle Side Effects in Patients Taking Statins for Cardiovascular Risk Prevention

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Primary hypercholesterolaemia
    • Hypercholesterolaemia
    Investigated Drugs:
    • Fluvastatin Sodium
    • Pitavastatin Calcium
    • Rosuvastatin Zinc
    Spain

  • Study on MB-CART2019.1 for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Not Eligible for High-Dose Chemotherapy and Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • B-cell lymphoma recurrent
    • B-cell lymphoma refractory
    Investigated Drugs:
    • Polatuzumab Vedotin
    • Zamtocabtagene Autoleucel
    • Bendamustine Hydrochloride
    Austria Belgium Croatia Czechia Finland France +9

  • Study on the Safety and Effects of HMB-001 for Patients with Glanzmann Thrombasthenia

    Recruiting

    2 1 1
    Investigated Drugs:
    • Hmb-001
    Belgium France Italy The Netherlands
Previous Page
1 … 437 438 439 440 441 … 1,653
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!